Company intelligence / Profile preview

Shanghai Caerulum Pharma Discovery

Shanghai, Shanghai, Chinacaerulumpharma.com ↗

Ownership: Private
Development stage: Other

Overview

Shanghai Caerulum Pharma Discovery is an integrated CRO providing comprehensive drug discovery and development services. It offers design/synthesis of pharmaceutical intermediates, positive control compounds, preclinical pharmacokinetics, safety evaluations, in vitro/in vivo screening, DMPK studies, and process development. The company has supported client molecules advancing into preclinical development through to Phase II clinical trials but does not have its own clinical pipeline.

Therapeutic areas: Other
Modalities: Small moleculePeptidesBiologic
Industry: Drug Discovery Services

Partnerships

Not specifically disclosed; collaborates with global pharma/biotech clients as a service provider.

Beyond the preview

Go deeper on Shanghai Caerulum Pharma Discovery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Caerulum Pharma Discovery.

Explore the full profile